CN105392476B - 药物软明胶胶囊剂型 - Google Patents

药物软明胶胶囊剂型 Download PDF

Info

Publication number
CN105392476B
CN105392476B CN201480022801.6A CN201480022801A CN105392476B CN 105392476 B CN105392476 B CN 105392476B CN 201480022801 A CN201480022801 A CN 201480022801A CN 105392476 B CN105392476 B CN 105392476B
Authority
CN
China
Prior art keywords
dosage form
perle
drug
gelatin
filler
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201480022801.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN105392476A (zh
Inventor
B·穆尔顿
S·麦库拉芙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alegen Treatment Co ltd
Allergan Pharmaceuticals Holdings Ireland ULC
Original Assignee
Warner Chilcott Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co LLC filed Critical Warner Chilcott Co LLC
Publication of CN105392476A publication Critical patent/CN105392476A/zh
Application granted granted Critical
Publication of CN105392476B publication Critical patent/CN105392476B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201480022801.6A 2013-03-15 2014-03-14 药物软明胶胶囊剂型 Active CN105392476B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794813P 2013-03-15 2013-03-15
US61/794,813 2013-03-15
PCT/US2014/027093 WO2014152226A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form

Publications (2)

Publication Number Publication Date
CN105392476A CN105392476A (zh) 2016-03-09
CN105392476B true CN105392476B (zh) 2018-11-02

Family

ID=50391548

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201480022801.6A Active CN105392476B (zh) 2013-03-15 2014-03-14 药物软明胶胶囊剂型

Country Status (11)

Country Link
US (1) US20140271837A1 (enExample)
EP (1) EP2968183B1 (enExample)
JP (1) JP6335269B2 (enExample)
CN (1) CN105392476B (enExample)
AU (1) AU2014240039B2 (enExample)
CA (1) CA2906619C (enExample)
ES (1) ES2681982T3 (enExample)
HK (1) HK1220113A1 (enExample)
IL (1) IL242438B (enExample)
MX (1) MX376951B (enExample)
WO (1) WO2014152226A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3031628B2 (ja) 1990-04-07 2000-04-10 株式会社日立製作所 洗濯乾燥機
JP3143355B2 (ja) 1995-03-28 2001-03-07 三洋電機株式会社 遠心脱水装置
US10673198B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-coupled laser with time varying beam characteristics
US10673199B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based saturable absorber
US10673197B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based optical modulator
JP2023548896A (ja) * 2020-11-13 2023-11-21 ファイザー・インク タラゾパリブ軟質ゼラチンカプセル剤形

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
CN101360485A (zh) * 2005-10-26 2009-02-04 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
AU1925697A (en) * 1996-03-12 1997-10-01 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
WO2005070949A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
US7067504B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
CA2612380C (en) 2005-06-16 2017-06-06 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
CA2610475C (en) 2005-07-12 2013-09-17 Warner Chilcott Company, Inc. Derivative prodrugs of ethinyl estradiol
EP1910402A2 (en) 2005-07-12 2008-04-16 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
EP2011496A1 (en) * 2007-07-03 2009-01-07 Indena S.P.A. Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
CN101360485A (zh) * 2005-10-26 2009-02-04 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统

Also Published As

Publication number Publication date
IL242438B (en) 2020-01-30
EP2968183B1 (en) 2018-05-09
MX2015012075A (es) 2016-05-10
AU2014240039A1 (en) 2015-10-15
ES2681982T3 (es) 2018-09-17
HK1220113A1 (zh) 2017-04-28
CA2906619C (en) 2021-11-16
US20140271837A1 (en) 2014-09-18
EP2968183A1 (en) 2016-01-20
JP6335269B2 (ja) 2018-05-30
MX376951B (es) 2025-03-07
AU2014240039B2 (en) 2019-01-24
JP2016513680A (ja) 2016-05-16
WO2014152226A1 (en) 2014-09-25
CA2906619A1 (en) 2014-09-25
CN105392476A (zh) 2016-03-09

Similar Documents

Publication Publication Date Title
KR102000435B1 (ko) 하이드로겔 패치 형태의 경피투여용 약학 조성물
US10744096B2 (en) Pharmaceutical soft gelatin capsule dosage form with modified guar gum
US9480667B2 (en) Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
JP6335269B2 (ja) 医薬ソフトゼラチンカプセル剤形
BRPI0907298B1 (pt) Preparação solúvel em água, sólida e no formato de película compreendendo álcool de polivinila e substância oleosa, e método para produzí-la
US20020036154A1 (en) Solid pharmaceutical dosage formulation of hydrophobic drugs
NZ712280B2 (en) Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20220104

Address after: New Jersey USA

Patentee after: Alegen treatment Co.,Ltd.

Address before: Irish Dublin

Patentee before: APTALIS PHARMA LTD.

Effective date of registration: 20220104

Address after: Irish Dublin

Patentee after: APTALIS PHARMA LTD.

Address before: Puerto Rico

Patentee before: WARNER CHILCOTT Co.,LLC

TR01 Transfer of patent right